Potentially
dilutive securities, on a weighted average basis, that were not included in the calculation of diluted net loss per share attributable
to common stockholders because their effect would be anti-dilutive are as follows (in common equivalent shares):
SCHEDULE
OF ANTI_DILUTIVE POTENTIALLY DILUTIVE SECURITIES
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| | |
For the Three Months Ended | | |
For the Nine Months Ended | |
| | |
March 31, | | |
March 31, | |
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| Options | |
| 4,706,125 | | |
| 4,977,117 | | |
| 4,672,317 | | |
| 5,340,569 | |
| Warrants | |
| 737,500 | | |
| 788,167 | | |
| 737,500 | | |
| 838,741 | |
| Total | |
| 5,443,625 | | |
| 5,765,284 | | |
| 5,409,817 | | |
| 6,179,310 | |
|